Atasever T, Babacan GB, Ekinci OB, Buyukkuscu A, et al. Prognostic value of PSMA PET-derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. Cancer Imaging 2026 Apr 30. doi: 10.1186/s40644-026-01036.
PMID: 42063136